"2012 was one heck of a year for new treatments against various different forms of leukemia. In the span of 5 months, the U.S. Food and Drug Administration approved four novel therapies. Drug approvals always come with a spike of media attention, but we at W2O Group have been curious as to how that flood of interest compares with other events throughout the year, not only in news, but in all of the other conversations we have online about cancer. So we decided to look into how we’re talking about cancer, both at the broadest level and in the context of more specific cancers and more specific communities." Continue reading the blog of a director at WCG, an independent strategic communications firm, here.
Read the full report, the Social Oncology Project, here.
No comments:
Post a Comment